The global dietary supplements market is forecast to reach $324.88bn by 2034, up from $186.36bn in 2025, according to a new report from Maximize Market Research.
The market is projected to expand at a 6.37% CAGR between 2026 and 2034, with rising health awareness, preventive healthcare and demand for personalised nutrition identified as key growth drivers.
The report covers a broad range of supplement categories, including vitamins, botanicals, minerals, proteins and amino acids, omega fatty acids, probiotics, prebiotics and postbiotics.
It also identifies tablets, capsules, softgels, powders, gummies and liquid products as key delivery formats.
Plant-based and personalised nutrition
According to the research, growing consumer interest in plant-based, vegan, clean-label and naturally derived supplements is influencing product development across major markets.
The report also highlights personalised nutrition as an area of increasing activity, with technologies including AI-driven recommendations, DNA-based nutrition, microbiome testing and wearable health data being explored to support more tailored supplement strategies.
Advanced delivery technologies, including liposomal formulations and sustained-release tablets, are also identified as areas of innovation, alongside continued development in sports nutrition, gut health, healthy ageing and weight management.
Regulatory challenges remain
While the market outlook is positive, Maximize Market Research identifies regulatory complexity and compliance costs as potential restraints.
Manufacturers operating across different regions must navigate varying requirements around ingredient safety, labelling, documentation, quality control and health claims.
The report identifies North America as the leading regional market, while Europe and Asia Pacific are also highlighted as significant markets for dietary supplements and nutraceutical products.
